他汀类药物的非调脂作用

被引：15

作者：

刘时武 ^{[1
]}

丁世芳 ^{[2
]}

机构：

[1] 南方医科大学

[2] 广州军区武汉总医院心内科

来源：

华南国防医学杂志 | 2008年 / 02期

关键词：

他汀类药物; 非调脂作用;

D O I：

10.13730/j.1009-2595.2008.02.023

中图分类号：

R96 [药理学];

学科分类号：

100602 ; 100706 ;

摘要：

引用

页码：63 / 65

页数：3

共 15 条

[1] Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome [J].

Devaraj, Sridevi ;

Chan, Emily ;

Jialal, Ishwarlal .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4489-4496

[2] Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease [J].

Tavridou, A. ;

Efthimiadis, A. ;

Efthimiadis, I. ;

Paschalidou, H. .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) :485-489

[3] Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease [J].

Watanabe, K ;

Sugiyama, S ;

Kugiyama, K ;

Honda, O ;

Fukushima, H ;

Koga, H ;

Horibata, Y ;

Hirai, T ;

Sakamoto, T ;

Yoshimura, M ;

Yamashita, Y ;

Ogawa, H .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (11) :2022-2030

[4] Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes [J].

Fuhrman, B ;

Koren, L ;

Volkova, N ;

Keidar, S ;

Hayek, T ;

Aviram, M .

ATHEROSCLEROSIS, 2002, 164 (01) :179-185

[5] Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease [J].

Seljeflot, I ;

Tonstad, S ;

Hjermann, I ;

Arnesen, H .

ATHEROSCLEROSIS, 2002, 162 (01) :179-185

[6] Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women [J].

Marchesi, S ;

Lupattelli, G ;

Siepi, D ;

Schillaci, G ;

Vaudo, G ;

Roscini, AR ;

Sinzinger, H ;

Mannarino, E .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (05) :617-621

[7]

Atorvastatin but not l -arginine improves endothelial function in type I diabetes mellitus: a double-blind study[J] . Michael J. Mullen,David Wright,Ann E. Donald,Sara Thorne,Hyeyoung Thomson,John E. Deanfield.Journal of the American College of Cardiology . 2000 (2)

[8] Long-term effects of pravastatin on plasma concentration of C-reactive protein [J].

Ridker, PM ;

Rifai, N ;

Pfeffer, MA ;

Sacks, F ;

Braunwald, E .

CIRCULATION, 1999, 100 (03) :230-235

[9]

Protective effect of fluvastatin sodium （XU-62-320）, a 3-hydroxy-3-methylglutaryl coenzyme a （HMG-CoA） reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro[J] . Kuniharu Suzumura,Mikiko Yasuhara,Keiko Tanaka,Toshikazu Suzuki.Biochemical Pharmacology . 1999 (6)

[10]

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels[J] . Paul M. Ridker,Nader Rifai,Marc A. Pfeffer,Frank M. Sacks,Lemuel A. Moye,Steven Goldman,Greg C. Flaker,Eugene Braunwald.Circulation . 1998 (9)

← 1 2 →